Skip to main content


Abdalla EK, Denys A, Chevalier P, et al: Total and segmental liver volume variations: implications for
liver surgery. Surgery. 2004; 135:404-410.
Abulkhir, A; Limongelli, P; Healey, AJ. et al: Preoperative Portal Vein Embolization for Major Liver
Resection: A Meta-Analysis Ann. Surg. 2008, 247: 49-57.
Antoniou, A; Lovegrove, RE.,Tilney HS; és mtsai: Meta-analysis of clinical outcome after first and second
liver resection for colorectal metastases. [Review] Surgery. 2007, 141(1):9-18.
Chijiiwa K. Kai M. Nagano M. Hiyoshi M. Ohuchida J. Kondo K.: Outcome of radical surgery for stage
IV gallbladder carcinoma. J. HBP Surg. 2007, 14:345-50.
Cho YB. Lee KU. Suh KS. És mtsai: Hepatic resection compared to percutaneous ethanol injection for
346 Gastro Update 2008
small hepatocellular carcinoma using propensity score matching.[see comment]. J. Gastroenterol. & Hepatol.
2007, 22:1643-9.
Choi D. Lim HK. Joh JW. és mtsai: Combined hepatectomy and radiofrequency ablation for multifocal
hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann. Surg. Oncology. 2007, 14:3510-8.
Colombato, L.: The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management
of Portal Hypertension. J. Clin. Gastroenterol. 2007,41: Suppl.3, S344-S351.
Cunha, A. Laurent, Ch. Rault, A; Couderc, P. Rullier, E Saric, J.: A Second Liver Resection Due to
Recurrent Colorectal Liver Metastases. Arch. Surg. 2007, 142:1144-1149.
Datta, HK, Malik M, Neely R, Dermot G.: Hepatic surgery-related hypophosphatemia. [Review] [123
refs] Clin. Chim. Acta. 2007, 380:13-23.
De Jong K P.: Multimodality treatment of liver metastases increases suitability for surgical treatment.
[Review] Aliment. Pharmacol. Ther. 2007, 26 (Suppl.2):161-169.
Delis SG. Madariaga J. Bakoyiannis A. Dervenis Ch.: Current role of bloodless liver resection.
[Review] [17 refs] World J. Gastroenterol. 2007, 13:826-9.
Di Maio M. De Maio E. Morabito A. és mtsai: Hormonal treatment of human hepatocellular carcinoma.
[Review] [29 refs] Ann. NY Acad. Sci. 2006, 1089:252-61.
Elias D. Goere D. Boige V. és mtsai: Outcome of posthepatectomy-missing colorectal liver metastases
after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin. Ann. Surg.
Oncology. 2007, 14:3188-94.
Fernandez FG, Ritter J, Goodwin JW, et al: Effect of steatohepatitis associated with irinotecan or
oxaplatin pretreatment on respectability of hepatic colorectal metastases. J Am Coll Surg. 2005; 200:845-853.
Ferrero A. Vigano L. Polastri R.és mtsai: Postoperative liver dysfunction and future remnant liver:
where is the limit? Results of a prospective study. World J Surg. 2007, 31:1643-51.
Figueras J, Burdio F, Ramos E, Torras J, Llado L, Lopez-Ben S, et al: Effect of subcentimetric nonpositive
resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Evidence from 663 liver resections. Ann Oncol 2007; 18:1190-1195.
Furrer K. Deoliveira ML. Graf R. Clavien PA: Improving outcome in patients undergoing liver surgery.
[Review] [143 refs] Liver International. 2007, 27(1):26-39,
Furst G. Schulte am Esch J. Poll LW.és mtsai: Portal vein embolization and autologous CD133+ bone
marrow stem cells for liver regeneration: initial experience. Radiology. 2007, 243:171-9.
Gertsch P. Vandoni RE. Pelloni A. Krpo A. Alerci M: Localized hepatic ischemia after liver resection: a
prospective evaluation. Ann. Surg. 2007, 246:958-64.
Gomez D, Homer-Vanniasinkam S, Graham AM, Prasad KR: Role of ischaemic preconditioning in liver
regeneration following major liver resection and transplantation. [Review] [218 refs] World J. Gastroenterol.
2007, 13:657-70.
Halazun, KJ, Al-Mukhtar A; Aldouri A; Malik HZ. Et al: Right Hepatic Trisectionectomy for Hepatobiliary
Diseases: Results and an Appraisal of Its Current Role Ann. Surg. 2007, 246: 1065-1074.
Halazun, KJ, Al-Mukhtar A, Aldouri A, et al: Right Hepatic Trisectionectomy for Hepatobiliary Diseases:
Results and an Appraisal of Its Current Role. Ann. Surg. 2007: 246 :1065-1074.
Hamady ZZ, Cameron IC, Wyatt J, et al: Resection margin in patients undergoing hepatectomy for colorectal
liver metastasis: a critical appraisal of the 1 cm rule. Eur J Surg Oncol. 2006;32:557-563.
Hamady ZZ, Malik HZ, Finch R, et al: Hepatic resection for colorectal metastasis: impact of tumour
size. Ann Surg Oncol. 2006; 13:1493-1499.
A máj 347
Hahn O., Szijártó A., Lotz G., Schaff Zs., Vígváry Z., Váli L., Kupcsulik P.: The effect of ischemic
preconditioning prior to intraoperative radiotherapy on ischemic and on reperfused rat liver. J.Surg.Res. 2007
Hashem B. El-Serag, K. Lenhard Rudolph: Hepatocellular Carcinoma: Epidemiology and Molecular
Carcinogenesis Gastroenterology 2007,132: 2557-2576.
Hashimoto, T; Kokudo T, Orii R; és mtsai: Intraoperative Blood Salvage During Liver Resection: A
Randomized Controlled Trial Ann.Surg. 2007, 245: 686-691.
Herman P. Machado MA. Machado MC.: Silkclasy: a simple way for liver transection during anatomic
hepatectomies J. Surg. Oncol. 2007, 95:86-9.
Ishizawa T. Yamamoto T. Sekikawa T.: The diagnostic values of measuring the liver volume in detecting
occult hepatic metastases from colorectal cancer. Hepato-Gastroenterol. 2007: 54:514-7.
Jaeck D. Oussoultzoglou E: Intrahepatic lymphatic invasion independently predicts poor survival and
recurrences after hepatectomy in patients with colorectal carcinoma liver metastases.[comment]. Ann. Surg.
Oncology. 2007, 14:3297-8.
Kaido, T: Recent randomized controlled trials in hepatectomy. [Review] [39 refs] Hepato-Gastroenterol.
2007, 54:1825-30.
Kamiyama T. Nakanishi K. Yokoo H.és mtsai: Efficacy of preoperative radiotherapy to portal vein tumor
thrombus in the main trunk or first branch in patients with hepatocellular carcinoma. Internat. J.Clin. Oncology.
2007, 12:363-8,
Kemeny N: Presurgical chemotherapy in patients being considered for liver resection. Oncologist 2007;
Knight, SR.; Friend, PJ.; Morris, PJ: Role of transplantation in the management of hepatic malignancy.
[Review] Br.J. Surg. 2007, 94:1319-1330.
Koch M. Kienle P. Logan E. és mtsai: Detection of disseminated tumor cells in liver biopsies of colorectal
cancer patients is not associated with a worse prognosis. Ann. Surg. Oncology. 2007, 14:810-7.
Koffron, AJ. Auffenberg, G; Kung, R; Abecassis, M: Evaluation of 300 Minimally Invasive Liver Resections
at a Single Institution: Less Is More Ann. Surg. 2007, 246: 385-394.
Korita PV. Wakai T. Shirai Y.és mtsai: Intrahepatic lymphatic invasion independently predicts poor survival
and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. [see comment] Ann.
Surg. Oncology. 2007, 14:3472-80.
Kuebler JP, Wieand HS, O’Connell MJ, Smith RE, Colangelo LH, Yothers G, et al: Oxaliplatin combined
with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer:
results from NSABP C-07. J Clin Oncol 2007; 25:2198-2204.
Lau WY. Lai EC: Salvage surgery following downstaging of unresectable hepatocellular carcinoma –
a strategy to increase resectability. [Review] [48 refs] Ann. Surg. Oncology. 2007, 14:3301-9.
Liu L. Cao Y. Chen C. és mtsai: Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis,
and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 2006,
Llouvet J, Ricci S, Mazzaferro V, Hilgard P, Raoul J, Zeuzem S, et al: Randomized phase III trial of
sorafenib vs. placebo in patients with advanced hepatocellular carcinoma. ASCO Annual Meeting Proceedings
Part II. J Clin Oncol 2007; 25 (Suppl): LBA1.
Luk J M., Wang X, Liu P, és mtsai: Traditional Chinese herbal medicines for treatment of liver fibrosis
and cancer: from laboratory discovery to clinical evaluation. Liver International 2007, 27: 879-890.
348 Gastro Update 2008
Malik HZ, Hamady ZZ, Adair R, et al: Prognostic influence of multiple hepatic metastases from
colorectal cancer. Eur J Surg Oncol. 2007; 33:468-473.
Malik HZ. Farid S. Al-Mukthar A. Anthoney A. Toogood GJ. Lodge JP. Prasad KR: A critical appraisal
of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Annals of Surgical
Oncology. 2007, 14:3519-26.
Massip-Salcedo M., J. Roselló-Catafau, J. Prieto, M. al: The response of the hepatocyte to
ischemia Liver International 2007, 27: 6-16.
Minagawa, M; Yamamoto, J; Miwa, S; és mtsai: Selection Criteria for Simultaneous Resection in
Patients With Synchronous Liver Metastasis Arch. Surg. 2006,141:1006-1012.
Morioka, D Egawa, H Kasahara, M et al: Outcomes of Adult-to-Adult Living Donor Liver Transplantation:
A Single Institution’s Experience With 335 Consecutive Cases. Ann. Surg. 2007, 245(2):315-325.
Moug SJ. Smith D. Leen E. Angerson WJ. Horgan PG: Selective continuous vascular occlusion and
perioperative fluid restriction in partial hepatectomy. Outcomes in 101 consecutive patients Eur. J. Surg.
Oncology. 2007, 33(8):1036-41.
Nagino M, Kamiya J, Nishio H, et al: Two hundred forty consecutive portal vein embolizations before
extended hepatectomy for biliary cancer surgical outcome and long-term follow-up. Ann Surg. 2006; 243:364-372.
Nordlinger B, Sorbye L, Collette L, Glimelius G, Poston GJ, Schlag PM, et al: Final results of the
EORTC intergroup randomized phase III study 40983 (EPOC) evaluating the benefit of peri-operative FOLFOX4
chemotherapy for patients with potentially resectable colorectal cancer liver metastases. ASCO Annual
Meeting Proceedings Part II. J Clin Oncol 2007; 25 (Suppl):LBA5.
Pandey D. Lee KH. Wai CT. Wagholikar G. Tan KC: Long term outcome and prognostic factors for large
hepatocellular carcinoma (10 cm or more) after surgical resection. Ann. Surg. Oncology. 2007:14:2817-23.
Pessaux, P. Regimbeau, J.-M. Dondero, F. Plasse, M.Mantz, J. Belghiti, J: Randomized clinical trial
evaluating the need for routine nasogastric decompression after elective hepatic resection. Br.J. Surg. 2007:
Petrowsky H, McCormack L, Trujillo M, et al: A prospective, randomized, controlled trial comparing
intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver
resection. Ann Surg. 2006; 244:921-930.
Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J, et al: Multicenter randomized trial of adjuvant
fluorouracil alone compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH
AURC 9002 trial. J Clin Oncol 2006; 24:4976-4982.
Puglisi, F; Aprile G; Fasola G: Hot topics and landmark studies from the 43rd annual meeting of the
American Society of Clinical Oncology [CONFERENCE REPORT] Anticancer Dugs 2008, 19:221-233.
Schirmang TC. Dupuy DE: Image-guided thermal ablation of nonresectable hepatic tumors using the
Cool-Tip radiofrequency ablation system. Expert Review of Medical Devices. 2007, 4:803-14.
Schwartz, M. ; Roayaie, S. Uva, P: Treatment of HCC in Patients Awaiting Liver Transplantation.
[Review] Amer.J. Transpl. 2007: 7:1875-1881.
Seki H. Ozaki T. Shiina M: Side-hole catheter placement for hepatic arterial infusion chemotherapy in
patients with liver metastases from colorectal cancer: long-term treatment and survival benefit. AJR. 2008,
Selzner, N. Pestalozzi, BC. Kadry, Z, Selzner,M, Wildermuth, S., Clavien, PA: Downstaging colorectal
liver metastases by concomitant unilateral portal vein ligation and selective intra-arterial chemotherapy. Br J.
Surg. 2006, 93:587-592.
Seo DD. Lee HC. Jang MK.és mtsai: Preoperative portal vein embolization and surgical resection in
A máj 349
patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial
chemoembolization. Ann. Surg. Oncology. 2007, 14:3501-9.
Shah SA. Cleary SP. Tan JC. és mtsai: An analysis of resection vs transplantation for early hepatocellular
carcinoma: defining the optimal therapy at a single institution. Ann. Surg. Oncology. 2007, 14:2608-14.
Shimizu H. Kimura F. Yoshidome H.és mtsai: Aggressive surgical approach for stage IV gallbladder
carcinoma based on Japanese Society of Biliary Surgery classification. J. HBP Surg. 2007, 14:358-65.
Smyrniotis V. Arkadopoulos N. Theodosopoulos T. és mtsai: Transdiaphragmatic approach facilitates
resection of large (>12 cm) liver tumors. J. HBP Surg. 2007, 14:383-6.
Steeghs N. Nortier JW. Gelderblom H: Small molecule tyrosine kinase inhibitors in the treatment of
solid tumors: an update of recent developments. [Review] [117 refs] Ann. Surg. Oncology. 14(2):942-53.
Stippel DL: Percutaneous, laparoscopic and open surgical radiofrequency ablation of malignant liver
lesions]. [Review] [47 refs] Zbl. Chir. 2007, 132:293-9.
Szijártó A., Batmunkh E., Hahn O., Mihály Z., Kreiss Á., Kiss A., Lotz G., Schaff Zs., Váli L., Blázovics A.,
Gero D., Szabó Cs., Kupcsulik P.: Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant
status. J.Surg.Res. 2007 142:72-80.
Toya R. Murakami R. Baba Y. és mtsai: Conformal radiation therapy for portal vein tumor thrombosis
of hepatocellular carcinoma. Radiother. & Oncol. 2007, 84:266-71.
Uhl M. Euringer W. Makowiec F. Adam U. Schneider A. Langer M: Portal vein embolization preparation
for major hepatic resection: a new standard in liver surgery]. [Review] [23 refs] RÖFO: 2007, 179:31-7.
Van Cutsem E, Nordlinger B, Adam R, Kohne CH, Pozzo C, Poston G, et al: Towards a pan-European
consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006; 42:2212-2221.
Veteläinen, R van Vliet, A; Gouma, DJ., van Gulik TM: Steatosis as a Risk Factor in Liver Surgery
[Review] Ann Surg. 2007, 245:20-30.
Vibert E. Bretagnol F. Alves A. Pocard M. Valleur P. Panis Y: Multivariate analysis of predictive factors
for early postoperative death after colorectal surgery in patients with colorectal cancer and synchronous unresectable
liver metastases. Dis. Colon & Rectum. 2007, 50:1776-82.
Vogl TJ. Zangos S. Balzer JO. Nabil M. Rao P. Eichler K. Bechstein WO. Zeuzem S. Abdelkader A:
Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results. [Review] [103 refs] RÕFO 2007: 179:1113-26.
Yokoyama Y. Nagino M. Nimura Y: Mechanism of impaired hepatic regeneration in cholestatic liver.
[Review] [95 refs] J.HBP Surg. 2007, 14:159-66.
Zorzi D. Laurent A. Pawlik TM. Lauwers GY. Vauthey JN. Abdalla EK: Chemotherapy-associated
hepatotoxicity and surgery for colorectal liver metastases. [Review] [86 refs] Br. J. Surg. 2007, 94:274-86.